Innovations in Rheumatic Disease Treatment

This chapter explores recent advancements in the treatment of rheumatoid arthritis and axial spondyloarthritis, focusing on findings from the American College of Rheumatology. It highlights the rapid effectiveness of JAK and TNF inhibitors, along with long-term clinical responses observed with bimikizumab and secukinumab. Additionally, it examines safety profiles and the impact of these treatments on inflammation and structural changes in patients over a two-year period.